0 results available. Select is focused ,type to refine list, press Down to open the menu,
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company’s lead product is Vyle...
The following section summarizes insights on Palatin Technologies Inc's Net Income to Common Excl Extra Items:
We've identified the following companies as similar to Palatin Technologies Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
Data is returned in millions. Please note, you need a Premium subscription to access data for ni_avail_excl.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Net Income to Common Excl Extra Items in the financials category include:
Represents the net income or loss available to common stockholders and is arrived after adjusting preferred stock dividends and other adjustments to n...
Palatin Technologies reported net income to common excl extra items of -26.952 M for the latest twelve months ending December 31, 2024 on its income statement.
The tables below summarizes Palatin Technologies’s Net Income to Common Excl Extra Items and common size over the last five years:
| Fiscal Year | Net Income to Common Excl Extra Items | Revenue | % Revenue |
|---|---|---|---|
| 2020-06-30 | -22.426 M | 117.989 T | −19,006.9% |
| 2021-06-30 | -33.596 M | -188.597 T | 17,813.9% |
| 2022-06-30 | -36.198 M | 1.468 M | −2,465.1% |
| 2023-06-30 | -24.037 M | 4.854 M | −495.2% |
| 2024-06-30 | -29.736 M | 4.49 M | −662.3% |
The tables below summarizes Palatin Technologies’s Net Income to Common Excl Extra Items and common size over the last four quarters:
| Quarter Ending | Net Income to Common Excl Extra Items | Revenue | % Revenue |
|---|---|---|---|
| 2024-03-31 | -8.436 M | zero | NA |
| 2024-06-30 | -8.25 M | 350 T | −2,357.3% |
| 2024-09-30 | -7.824 M | NA | NA |
| 2024-12-31 | -2.442 M | NA | NA |
The chart above depicts the distribution of net income to common excl extra items for companies operating in the Healthcare sector in the Developed economic region. Over 2,475 companies were considered in this analysis, and 2,380 had meaningful values. The average net income to common excl extra items of companies in the sector is -1.281 M with a standard deviation of 146.9 M.
Palatin Technologies Inc's Net Income to Common Excl Extra Items of -26.952 M ranks in the 25.5% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,480 |
| Included Constituents | 2,380 |
| Min | -386.3 M |
| Max | 1.32 B |
| Median | -5.36 M |
| Mean | -1.281 M |
| Standard Deviation | 146.9 M |
You can find companies with similar net income to common excl extra items using this stock screener.